Tesla Inc
NASDAQ: TSLA
$454.13
Closing Price on December 26, 2024
TSLA Articles
EV stocks were losing some of their recent gains, and one biotech has announced a new federal investigation.
Published:
Shares of electric vehicle makers are hot, hot, hot, right now. How long can the run last?
Published:
Here's a look a four meme stocks that were moving on Monday.
Published:
Meme stocks had a mixed day on Friday, with one big loser and one big winner, and Monday's premarket trading seemed a bit muted.
Published:
Shares of marijuana grower and retailer Sundial exploded higher Friday morning. They had almost reached a buck, and some retail investors are predicting a rocket ride to $4.20.
Published:
Rivian's blockbuster IPO on Wednesday lifted the shares of virtually every EV maker. Even legacy carmakers got a boost.
Published:
Here's a look at four meme stocks that were having both good and bad days on Wednesday.
Published:
Markets closed lower Tuesday for the first time in more than a week, and several meme stocks were hit hard.
Published:
Tuesday was not shaping up to be a winner on Tuesday. The same was true for meme stocks. As a group, losers outnumbered winners by about three to one.
Published:
Winners and losers among meme stocks in Tuesday's premarket, plus one really, really OG stock that's having a big day.
Published:
Meme stocks, like Monday's broad markets, were trading higher, with more winners than losers and more new highs than new lows.
Published:
Monday afternoon's top analyst upgrades and downgrades included Canopy Growth, Pioneer Natural Resources, Shake Shack, Tesla, Toll Brothers, VMWare and Volkswagen.
Published:
With one major exception, several of last week's best-performing meme stocks were off to another good start. Plus, there's some potentially good news for investors in Chinese education and tutoring...
Published:
A strong October jobs report lit a fire under traders in Friday's premarket. One of Thursday's big movers added a bit more Friday morning and another was dropping after reporting earnings.
Published:
A company developing a treatment for Alzheimer's disease got a big boost Thursday when a journal in which the company published a report said it found no basis for allegations of data and image...
Published: